Millions of syringe products in chaos as FDA probes China-made devices

At least 60 million syringes and infusion pumps are in turmoil as the FDA investigates China-made plastic syringes that changed dimensions. 

Advertisement

On Nov. 30, the FDA warned healthcare workers to avoid plastic syringes made in China after several manufacturers changed syringe dimensions, which the agency said is causing leaks and breakage. 

In the two weeks prior to the FDA’s warning, U.S. medical devicemakers issued warnings about their syringe infusion pumps having compatibility issues with modified syringes, including 32 million Cardinal Health syringes that have different dimensions than older brands.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.